Interleukin 17 modulates the immune response to vaccinia virus infection

Virology. 2002 Jul 20;299(1):56-63. doi: 10.1006/viro.2002.1400.

Abstract

Interleukin 17 (IL-17) is a newly identified cytokine that has a homolog in herpesvirus saimiri. We inserted murine IL-17 into vaccinia virus to study the role of IL-17 in viral infection. Vaccinia virus expressing IL-17 (vv-IL17) and its parental control virus (vv-pRB) grew to similar titers in vitro; however, vv-IL17 was more virulent in mice with a threefold lower LD(50) than for vv-pRB, and mean time to death of 2.8 days versus 4.5 days. Mice infected with vv-IL17 had higher titers of virus in the ovaries (P < 0.02) and showed a decrease in NK cell cytotoxicity (P < 0.02) on day 3 after infection. No significant difference was found in CTL activity. In addition, a significant decrease in IgG2a (P < 0.01) and increases in IgG1, IgG3, and IgA (P < 0.03) vaccinia virus-specific antibody titers were observed in mice infected with vv-IL17 versus vv-pRB, suggesting a Th-2-like response to infection. These data indicate that IL-17 modulates the immune response during virus infection.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antibodies, Viral / blood
  • Female
  • Immunoglobulin A / blood
  • Immunoglobulin G / blood
  • Interleukin-17 / genetics
  • Interleukin-17 / physiology*
  • Killer Cells, Natural / immunology
  • Mice
  • Mice, Inbred BALB C
  • Ovary / virology
  • Recombination, Genetic
  • Spleen / immunology
  • T-Lymphocytes, Cytotoxic / immunology
  • Time Factors
  • Vaccinia / blood
  • Vaccinia / immunology*
  • Vaccinia / mortality
  • Vaccinia virus / genetics
  • Vaccinia virus / pathogenicity*
  • Virulence

Substances

  • Antibodies, Viral
  • Immunoglobulin A
  • Immunoglobulin G
  • Interleukin-17